AI MEDTECH specialist Weixen participated in the Vietnam Gastroenterology Association (VNAGE 2025) held in Vietnam for two days from October 31st and announced the results of a study on early gastric cancer diagnosis using the company's AI endoscope, 'WayMed Endo'.
This clinical trial, conducted by a research team led by Professors Kim Ji-hyun and Kim Yun-ah of the Department of Gastroenterology at Yonsei University Gangnam Severance Hospital, compared the accuracy of AI endoscopy and that of specialists in diagnosing invasion depth. The results showed that the AI achieved a sensitivity of 96%, a specificity of 95%, and an overall accuracy of 96%, demonstrating superior diagnostic performance compared to specialists (accuracy of 71%). Consistent interpretation accuracy was maintained regardless of lesion size or shape, demonstrating the reliable diagnostic potential of the AI.
This study demonstrates that AI can demonstrate clinical judgment superior to that of a specialist, not only in the detection of early gastric cancer but also in the prediction of lesion invasion depth. This suggests that AI could support physician decision-making in real-time diagnostic assistance and treatment strategy development during future endoscopic procedures.
At the local academic conference, after the presentation, questions and discussions from medical professionals followed, and medical professionals in Southeast Asia showed great interest in the clinical application of AI technology in early gastric cancer diagnosis.
Kim Kyung-nam, CEO of Waysen, said, “The research results are significant in that Waymed Endo has improved the accuracy and consistency of early gastric cancer diagnosis,” and added, “We plan to accelerate our entry into the global market by expanding the introduction and sales of AI endoscopes in overseas markets, including Vietnam.”
- See more related articles
You must be logged in to post a comment.